$CYBK HUGE MJ News this week courtesy of our

New Post Public Reply Private Reply Replies (0) Message Board
MicroCapStocksRock StockMasterTalk #1438
$CYBK HUGE MJ News this week courtesy of our friends at http://www.fullimpactstockpicks.com


Image

Cyber Kiosk Solutions Is Taking Steps To Create Multiple Revenue Streams In The Legalized Marijuana Industry

Cyber Kiosk Solutions, Inc. (PC) (USOTC:CYBK)

Today : Thursday 6 March 2014

CORAL SPRINGS, Fla., March 5, 2014 /PRNewswire/ -- Cyber Kiosk Solutions, Inc. (OTC Pink: CYBK), hereafter referred to as the "Company" or "CYBK" is pleased to announce that the Company has taken steps to create multiple streams of  revenue by leveraging off the Company's relationships in the legalized marijuana industry.

The Company has received commitments from 10 dispensaries across Colorado and New Jersey through its relationship marketing efforts and expects to grow that number significantly throughout 2014.  In addition to the dispensaries agreeing to test and use the Company's software and mobile e-wallet consumer ordering app in the near future, they have also agreed to place marijuana kiosks and sell other products over the counter supplied by CYBK.  The Company has identified two companies and is in the process of securing Master Distribution Rights and online exclusive sales agreements with the two companies.  News and details of the products and agreements are expected to be released within the next 3 weeks.

The Company's consumer e-wallet ordering app will connect smart phone users to the Company's age/ID verification software and allow them to review the dispensaries different products and allow them to pay for them through the mobile app when that service becomes 100% legal.  The Company expects this portion of revenues to be the largest of all revenue streams due to transactional and processing revenues of all the dispensaries mobile app customers. The Company's focus is to aggressively expand the app user base into all legalized marijuana states.

Revenue projections for CYBK's business vertical in the legalized marijuana industry, is expected to be released in the coming weeks.

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

CONTACT:

Chris Clarke 
investor@cyber-thingy.com
954-509-3748

SOURCE Cyber Kiosk Solutions, Inc.

Copyright 2014 PR Newswire

My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care

Updated Category News Views 203

Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...

Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series

Updated Category News Views 162

Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...

Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects

Updated Category News Views 249

Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 187

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading
Investors Take Note: Legal Options for Shareholders Explored

Updated Category News Views 61

Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...

Continue Reading